Avilex Pharma Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.45M

  • Investors
  • 4

Avilex Pharma General Information

Description

Developer of neuroprotective therapeutics designed to treat acute ischemic stroke and neurological damage. The company focuses on discovering and developing affinity dimeric peptide inhibitors that target postsynaptic density protein complexes to block excitotoxic signaling cascades without impairing baseline synaptic transmission, conducts extensive preclinical pharmacokinetic and pharmacodynamic characterization; and advances clinical-stage drug candidates through translational development, enabling neurologists, critical care physicians, and clinical researchers to mitigate cerebral ischemic damage, preserve neurological tissue, and improve survival and recovery outcomes for acute stroke patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ole Maaloes Vej 3
  • 2200 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Ole Maaloes Vej 3
  • 2200 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avilex Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 20-Sep-2019 $1.45M Completed Clinical Trials - Phase 1
4. Grant 08-Jun-2015 Completed Clinical Trials - Phase 1
3. Seed Round 12-May-2015 Completed Clinical Trials - Phase 1
2. Seed Round 15-Apr-2013 $1.75M $1.75M Completed Clinical Trials - Phase 1
1. University Spin-Out 01-Jan-2012 Completed Startup
To view Avilex Pharma’s complete valuation and funding history, request access »

Avilex Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Avilex Pharma’s complete cap table history, request access »

Avilex Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neuroprotective therapeutics designed to treat acute ischemic stroke and neurological damage. The company f
Drug Discovery
Copenhagen, Denmark
4 As of 2025

Portland, OR
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avilex Pharma Competitors (9)

One of Avilex Pharma’s 9 competitors is Aronora, a Venture Capital-Backed company based in Portland, OR.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aronora Venture Capital-Backed Portland, OR
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Anthos Therapeutics Formerly PE-Backed East Hanover, NJ
Walden Biosciences Venture Capital-Backed Cambridge, MA
Basking Biosciences Venture Capital-Backed Cary, NC
You’re viewing 5 of 9 competitors. Get the full list »

Avilex Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avilex Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Denmark's Export and Investment Fund Venture Capital Minority
Wellcome Trust Limited Partner
Novo Holdings Venture Capital Minority
University of Copenhagen University
To view Avilex Pharma’s complete investors history, request access »

Avilex Pharma FAQs

  • When was Avilex Pharma founded?

    Avilex Pharma was founded in 2012.

  • Where is Avilex Pharma headquartered?

    Avilex Pharma is headquartered in Copenhagen, Denmark.

  • What is the size of Avilex Pharma?

    Avilex Pharma has 4 total employees.

  • What industry is Avilex Pharma in?

    Avilex Pharma’s primary industry is Drug Discovery.

  • Is Avilex Pharma a private or public company?

    Avilex Pharma is a Private company.

  • What is the current valuation of Avilex Pharma?

    The current valuation of Avilex Pharma is .

  • What is Avilex Pharma’s current revenue?

    The current revenue for Avilex Pharma is .

  • How much funding has Avilex Pharma raised over time?

    Avilex Pharma has raised $3.98M.

  • Who are Avilex Pharma’s investors?

    Denmark's Export and Investment Fund, Wellcome Trust, Novo Holdings, and University of Copenhagen have invested in Avilex Pharma.

  • Who are Avilex Pharma’s competitors?

    Aronora, Neurona Therapeutics, Anthos Therapeutics, Walden Biosciences, and Basking Biosciences are some of the 9 competitors of Avilex Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process